Former P&G exec Susan Arnold joins Carlyle Group as operating executive
NEW YORK — The Carlyle Group has hired former Procter & Gamble executive Susan Arnold as an operating executive in the Global Consumer & Retail group. Arnold begins her new role at the firm in September.
As an operating executive, Arnold will provide strategic guidance to Carlyle professionals throughout the investment process, from sourcing to acquisition to exit and advise portfolio company executives on management, operational, branding and growth strategies.
Arnold joined P&G in 1980 and retired in 2009. Prior to serving as president of P&G’s $50 billion Global Business Unit, she held various positions within the firm, including vice chairman of Global Beauty Care and Health, and president of Global Personal Beauty and Global Feminine Care. She currently serves on the board of directors of Disney and McDonalds.
“We are pleased to welcome Susan to the Carlyle team following a remarkable 29-year career at Procter & Gamble. Susan’s depth and scope of strategic and operational experience in the consumer space will help us to create value in our existing portfolio and to make new promising investments,” stated Sandra Horbach, Carlyle managing director and head of the Global Consumer & Retail group.
The Consumer & Retail group has led Carlyle’s acquisition of numerous companies, including: Dunkin’ Brands, philosophy, NBTY and CVC.
No comments found
Walgreens announces enhanced Daily Living team of key marketing and merchandising execs
DEERFIELD, Ill. — Walgreens on Wednesday announced an enhanced Daily Living business organization with the promotion and leadership expansion of key marketing and merchandising executives to further accelerate the company’s strategic growth drivers and advance its vision to be the first choice in health and daily living for everyone in America, and beyond.
The promotions and other changes in Walgreens Daily Living organization, which are effective Oct. 1, accompany the announcement today by Walgreens and Alliance Boots GmbH that Alex Gourlay, chief executive of Alliance Boots health and beauty division, has been named Walgreens executive vice president, president of customer experience and daily living. Reporting to Walgreens president and CEO Greg Wasson, Gourlay will lead the enhanced Walgreens Daily Living organization overseeing U.S. merchandising, marketing, customer insights, customer experience and daily living products and promotions.
“With our enhanced Daily Living and merchandising organization, combined with Alex Gourlay’s experience and expertise in global health and beauty, we are further expanding and complementing Walgreens already strong leadership team including Mark Wagner, president of operations and community management; Kermit Crawford, president of pharmacy, health and wellness; Graham Atkinson, our chief marketing officer and the creator of our 79-million member Balance Rewards loyalty program; and Sona Chawla, president of e-commerce and our omni-channel strategy,” said Wasson. “By combining the best marketing and merchandising practices of Walgreens and Alliance Boots, we are accelerating our ‘Well Experience’ strategy to step out of the traditional drug store format and create a truly differentiated experience for customers and patients.”
Today’s announcement includes a number of promotions and expansion of leadership roles of Walgreens Daily Living and merchandising executives:
- Bryan Pugh becomes corporate vice president, U.S. merchandising program development and execution. As Walgreens continues to hone and expand transformational merchandise programs and prepares for further joint merchandise initiatives with Alliance Boots across beauty, personal care, health and wellness, Pugh’s newly created role will bridge operations and merchandising functions and oversee rollout of new merchandising initiatives to the field, including operating standards, cross-functional deployment and flagship rollout.
- Moe Alkemade becomes group vice president, global sourcing. With his deep experience in developing and marketing consumer-packaged goods programs, Moe successfully led the restructuring and strong growth trajectory of Walgreens private brand portfolio, and established the foundation for Walgreens global sourcing capabilities. In his newly created role, Alkemade will focus on optimizing global sourcing and Daily Living buying synergies with Alliance Boots and AmerisourceBergen.
- Shannon Curtin is promoted to group vice president and general merchandise manager of beauty. Curtin will accelerate development and growth of Walgreens beauty proposition and customer experience across the United States, particularly underserved U.S. markets, and collaborate with the Alliance Boots and global partnership teams in maximizing U.S. opportunities for the Boots beauty proposition.
- Robert Tompkins is promoted to group vice president and general merchandise manager of health and wellness. Tompkins will accelerate development of innovative health-and-wellness products and programs for the U.S., collaborating with Alliance Boots and global partnership teams on joint program development.
- Jim Jensen becomes divisional vice president and general merchandise manager of seasonal and general merchandise, providing high-level, single-accountability focus on seasonal daily living products and promotions that are a key driver in Walgreens monthly daily living sales.
- Beth Stiller is promoted to group vice president of category planning, formats and innovation, and takes on an expanded role in merchandising with responsibility for category development, space planning, merchandise formats and program innovation, and private brands.
- Linda Severin, formerly of Kroger, where she led the redevelopment of its private brand portfolio, joins Walgreens as divisional vice president of private brands, responsible for product development, brand management and program execution of Walgreens private brands.
Like this story? Find us on Facebook for more insight, analysis and the latest in drug store news. Join the conversation.
No comments found
FDA raises generic drug user fees for 2014
WASHINGTON — The U.S. Food and Drug Administration this past weekend announced new fee rates for fiscal year 2014, including the abbreviated new drug application fee.
According to the Federal Register, the daily journal of the U.S. government, the FDA announced new rates for the abbreviated new drug application (ANDA), prior approval supplement to an approved ANDA (PAS), drug master file (DMF), generic drug active pharmaceutical ingredient (API), and finished dosage form (FDF) facilities user fees related to the Generic Drug User Fee Program.
The new fee for an ANDA is now set at $63,860, up approximately 24% from the current $51,520. The PAS will similarly be raised by 24%, to $31,930. The FDF fee increased to $220,152, a jump of 25%. The largest percent increase hit the DMF fee, which rose nearly 48% to $31,460. However, the API fee was lowered to $34,515.
FDA now refunds 75% of the original filing fee in all instances of refuse-to-receive with the exception of failure to pay fees. Therefore, an application that is refused on the first attempt, amended, refiled and accepted for review would pay a total of $78,825, or 125% of the standard amount. - Penina Mezei Americare